These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 3561773)

  • 1. Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study.
    Jankovic J; Orman J
    Neurology; 1987 Apr; 37(4):616-23. PubMed ID: 3561773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of botulinum toxin in Meige's disease.
    Maurri S; Brogelli S; Alfieri G; Barontini F
    Riv Neurol; 1988; 58(6):245-8. PubMed ID: 3247565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blepharospasm, Meige syndrome, and hemifacial spasm: treatment with botulinum toxin.
    Mauriello JA
    Neurology; 1985 Oct; 35(10):1499-500. PubMed ID: 4033932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local side effects of botulinum toxin injections.
    Patrinely JR; Whiting AS; Anderson RL
    Adv Neurol; 1988; 49():493-500. PubMed ID: 3278553
    [No Abstract]   [Full Text] [Related]  

  • 5. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin.
    Kraft SP; Lang AE
    CMAJ; 1988 Nov; 139(9):837-44. PubMed ID: 3052771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blepharospasm and oromandibular-laryngeal-cervical dystonia: a controlled trial of botulinum A toxin therapy.
    Jankovic J
    Adv Neurol; 1988; 50():583-91. PubMed ID: 3041763
    [No Abstract]   [Full Text] [Related]  

  • 7. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.
    Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC
    Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of treatment with botulinum toxin on neurogenic blepharospasm.
    Elston JS; Russell RW
    Br Med J (Clin Res Ed); 1985 Jun; 290(6485):1857-9. PubMed ID: 3924284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact on quality of life of botulinum toxin treatments for spasmodic dysphonia and oromandibular dystonia.
    Bhattacharyya N; Tarsy D
    Arch Otolaryngol Head Neck Surg; 2001 Apr; 127(4):389-92. PubMed ID: 11296046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indications for botulinum toxin in neurology].
    Ghika J; Küntzer T; Regli F
    Rev Med Suisse Romande; 1994 Jun; 114(6):551-5. PubMed ID: 8047771
    [No Abstract]   [Full Text] [Related]  

  • 11. Botulinum A toxin treatment for blepharospasm and Meige syndrome: report of 100 patients.
    Poungvarin N; Devahastin V; Chaisevikul R; Prayoonwiwat N; Viriyavejakul A
    J Med Assoc Thai; 1997 Jan; 80(1):1-8. PubMed ID: 9078810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin treatment in clinical neurology.
    Van den Bergh P
    Acta Neurol Belg; 1995; 95(2):70-9. PubMed ID: 7618431
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of onabotulinum toxin type A injections in patients with Meige's syndrome.
    Duarte A; Coutinho L; Germiniani FMB; Teive HAG
    Arq Neuropsiquiatr; 2024 Apr; 82(4):1-7. PubMed ID: 38641339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
    Cardoso F
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm.
    Jankovic J; Schwartz K; Donovan DT
    J Neurol Neurosurg Psychiatry; 1990 Aug; 53(8):633-9. PubMed ID: 2213039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurophysiological observations on the effects of botulinum toxin treatment in patients with dystonic blepharospasm.
    Valls-Sole J; Tolosa ES; Ribera G
    J Neurol Neurosurg Psychiatry; 1991 Apr; 54(4):310-3. PubMed ID: 1647444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of treatment of idiopathic blepharospasm with botulinum toxin injections.
    Elston JS
    Br J Ophthalmol; 1987 Sep; 71(9):664-8. PubMed ID: 3663559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Botulinum toxin A in therapy of craniocervical dystonias and hemifacial spasm].
    Thill R; Költringer P; Reisecker F; Maller J; Leblhuber F
    Acta Med Austriaca; 1991; 18(5):125-9. PubMed ID: 1796725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, placebo-controlled, crossover clinical trial of super blue-green algae in patients with essential blepharospasm or Meige syndrome.
    Vitale S; Miller NR; Mejico LJ; Perry JD; Medura M; Freitag SK; Girkin C
    Am J Ophthalmol; 2004 Jul; 138(1):18-32. PubMed ID: 15234278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.